<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1255" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1255/" /><meta name="ncbi_pagename" content="ARSACS - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>ARSACS - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="ARSACS" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2012/10/11" /><meta name="citation_author" content="Sascha Vermeer" /><meta name="citation_author" content="Bart P van de Warrenburg" /><meta name="citation_author" content="Erik-Jan Kamsteeg" /><meta name="citation_pmid" content="20301432" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1255/" /><meta name="citation_keywords" content="Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay" /><meta name="citation_keywords" content="Spastic Ataxia of Charlevoix-Saguenay" /><meta name="citation_keywords" content="Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay" /><meta name="citation_keywords" content="Spastic Ataxia of Charlevoix-Saguenay" /><meta name="citation_keywords" content="Sacsin" /><meta name="citation_keywords" content="SACS" /><meta name="citation_keywords" content="ARSACS" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="ARSACS" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Sascha Vermeer" /><meta name="DC.Contributor" content="Bart P van de Warrenburg" /><meta name="DC.Contributor" content="Erik-Jan Kamsteeg" /><meta name="DC.Date" content="2012/10/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1255/" /><meta name="description" content="ARSACS (autosomal recessive spastic ataxia of Charlevoix-Saguenay) is characterized in individuals born in Quebec Province by early-onset (age 12-18 months) difficulty in walking and gait unsteadiness. In individuals with ARSACS born outside the Province of Quebec, onset is often delayed until later childhood and even adulthood. Ataxia, dysarthria, spasticity, extensor plantar reflexes, distal muscle wasting, a distal sensorimotor neuropathy predominant in the legs, and horizontal gaze-evoked nystagmus constitute the most frequent progressive neurologic signs. Increased demarcation of the retinal nerve fibers located near the vessels close to the optic disc (formerly designated as yellow streaks of hypermyelinated fibers) is very common in individuals with ARSACS who originate from Quebec but may be absent in non-Quebec-born individuals. Individuals with ARSACS born in the Province of Quebec become wheelchair bound at the average age of 41 years; cognitive skills are preserved in the long term as individuals remain able to perform daily living tasks late into adulthood. Death commonly occurs in the sixth decade." /><meta name="og:title" content="ARSACS" /><meta name="og:type" content="book" /><meta name="og:description" content="ARSACS (autosomal recessive spastic ataxia of Charlevoix-Saguenay) is characterized in individuals born in Quebec Province by early-onset (age 12-18 months) difficulty in walking and gait unsteadiness. In individuals with ARSACS born outside the Province of Quebec, onset is often delayed until later childhood and even adulthood. Ataxia, dysarthria, spasticity, extensor plantar reflexes, distal muscle wasting, a distal sensorimotor neuropathy predominant in the legs, and horizontal gaze-evoked nystagmus constitute the most frequent progressive neurologic signs. Increased demarcation of the retinal nerve fibers located near the vessels close to the optic disc (formerly designated as yellow streaks of hypermyelinated fibers) is very common in individuals with ARSACS who originate from Quebec but may be absent in non-Quebec-born individuals. Individuals with ARSACS born in the Province of Quebec become wheelchair bound at the average age of 41 years; cognitive skills are preserved in the long term as individuals remain able to perform daily living tasks late into adulthood. Death commonly occurs in the sixth decade." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1255/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/arsacs/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1255/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BAF56E0404AC10000000007B002CC.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1255_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1255_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/arid1b-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/asah1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1255_"><span class="title" itemprop="name">ARSACS</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay, Spastic Ataxia of Charlevoix-Saguenay</div><p class="contrib-group"><span itemprop="author">Sascha Vermeer</span>, MD, PhD, <span itemprop="author">Bart P van de Warrenburg</span>, MD, PhD, and <span itemprop="author">Erik-Jan Kamsteeg</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1255_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1255_ai__"><div class="contrib half_rhythm"><span itemprop="author">Sascha Vermeer</span>, MD, PhD<div class="affiliation small">Radboud University Nijmegen Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.ncmu.neg@reemrev.s" class="oemail">ln.ncmu.neg@reemrev.s</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Bart P van de Warrenburg</span>, MD, PhD<div class="affiliation small">Radboud University Nijmegen Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.ncmu.oruen@grubnerrawednav.b" class="oemail">ln.ncmu.oruen@grubnerrawednav.b</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Erik-Jan Kamsteeg</span>, PhD<div class="affiliation small">Radboud University Nijmegen Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.ncmu.neg@geetsmak.e" class="oemail">ln.ncmu.neg@geetsmak.e</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 9, 2003</span>; Last Update: <span itemprop="dateModified">October 11, 2012</span>.</p><p><em>Estimated reading time: 15 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="arsacs.Summary" itemprop="description"><h2 id="_arsacs_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>ARSACS (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spastic ataxia of Charlevoix-Saguenay) is characterized in individuals born in Quebec Province by early-onset (age 12-18 months) difficulty in walking and gait unsteadiness. In individuals with ARSACS born outside the Province of Quebec, onset is often delayed until later childhood and even adulthood. Ataxia, dysarthria, spasticity, extensor plantar reflexes, distal muscle wasting, a distal sensorimotor neuropathy predominant in the legs, and horizontal gaze-evoked nystagmus constitute the most frequent progressive neurologic signs. Increased demarcation of the retinal nerve fibers located near the vessels close to the optic disc (formerly designated as yellow streaks of hypermyelinated fibers) is very common in individuals with ARSACS who originate from Quebec but may be absent in non-Quebec-born individuals. Individuals with ARSACS born in the Province of Quebec become wheelchair bound at the average age of 41 years; cognitive skills are preserved in the long term as individuals remain able to perform daily living tasks late into adulthood. Death commonly occurs in the sixth decade.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Neuroimaging reveals atrophy of the superior vermis and cerebellar hemispheres next to linear hypointensities in the pons. <i>SACS</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause ARSACS. More than 100 different pathogenic variants have been identified in <i>SACS</i>. About 96% of individuals with ARSACS from northeastern Quebec are homozygotes or compound heterozygotes for two founder variants.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Physical therapy and oral medications such as baclofen to control spasticity in the early phase of the disease may prevent tendon shortening and joint contractures and, hence, may help to postpone major functional disabilities until severe muscle weakness or cerebellar ataxia occur; urinary urgency and incontinence may be controlled with low doses of amitryptiline or oxybutynin; custom-made leg braces may improve control of spasticity; during school years, speech therapy and psychological support may help enhance academic performance.</p><p><i>Surveillance:</i> Annual neurologic examination, referral to neuro-rehabilitation unit.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ARSACS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being neither affected nor a carrier. Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3. Carrier testing and prenatal testing for pregnancies at increased risk are possible if both pathogenic alleles of an affected family member have been identified.</p></div></div><div id="arsacs.Diagnosis"><h2 id="_arsacs_Diagnosis_">Diagnosis</h2><div id="arsacs.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>ARSACS is clinically characterized by a progressive cerebellar syndrome, peripheral neuropathy, and spasticity. Disease onset is usually in early childhood, often leading to delayed walking because of gait unsteadiness in very young infants.</p><p>The clinical picture is fairly typical, consisting of the following triad of symptoms:</p><ul><li class="half_rhythm"><div>Progressive cerebellar ataxia</div></li><li class="half_rhythm"><div>Peripheral neuropathy with distal wasting and weakness</div></li><li class="half_rhythm"><div>Spasticity of the lower limbs</div></li></ul><p>Ophthalmologic examination may show increased demarcation of retinal nerve fibers. However, absence of this finding does not exclude ARSACS.</p></div><div id="arsacs.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Gene.</b>
<i>SACS</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spastic ataxia of Charlevoix-Saguenay (ARSACS).</p><div id="arsacs.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in ARSACS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1255/table/arsacs.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arsacs.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SACS</i></td><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants</td><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="#arsacs.Molecular_Genetics">6594delT</a> and <a href="#arsacs.Molecular_Genetics">5254C&#x0003e;T</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial- or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions</td><td headers="hd_h_arsacs.T.molecular_genetic_testing_used_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="arsacs.TF.1.1"><p class="no_margin">See <a href="/books/n/gene/shortname/#shortname.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="arsacs.TF.1.2"><p class="no_margin">See <a href="#arsacs.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="arsacs.TF.1.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="arsacs.TF.1.4"><p class="no_margin">Founder variants in individuals from northeastern Quebec [<a class="bk_pop" href="#arsacs.REF.mercier.2001.255">Mercier et al 2001</a>]. 92.6% of individuals with ARSACS are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the 6594delT variant; 3.7% of individuals with ARSACS are compound heterozygotes for the 6594delT <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> and a 5254C&#x0003e;T <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant [<a class="bk_pop" href="#arsacs.REF.richter.1999.768">Richter et al 1999</a>].</p></div></dd><dt>5. </dt><dd><div id="arsacs.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="arsacs.TF.1.6"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>7. </dt><dd><div id="arsacs.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#arsacs.REF.breckpot.2008.1050">Breckpot et al [2008]</a>, <a class="bk_pop" href="#arsacs.REF.terracciano.2009.151">Terracciano et al [2009]</a>, <a class="bk_pop" href="#arsacs.REF.baets.2010.1181">Baets et al [2010]</a></p></div></dd></dl></div></div></div></div><div id="arsacs.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> If an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is clinically suspected of having ARSACS, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of all coding exons and their flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> sequences is performed. If only one <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, additional <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> may be performed. Also, when one or more <i>SACS</i> exons fail to be amplified by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a>, deletion testing should be performed to determine if there is homozygosity for a deletion.</p><p><b>Carrier testing for at-risk relatives</b> requires prior identification of the pathogenic variants in the family. Note: Carriers are heterozygotes for this <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder and are not at risk of developing the disorder.</p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p></div></div><div id="arsacs.Clinical_Description"><h2 id="_arsacs_Clinical_Description_">Clinical Description</h2><div id="arsacs.Natural_History"><h3>Natural History</h3><p>ARSACS (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spastic ataxia of Charlevoix-Saguenay) defines a spastic ataxia usually of late-infantile onset in individuals born in Quebec, first described in 1978 among a cohort of about 325 French-Canadian individuals from 200 families born in the Saguenay-Lac-St-Jean area of northeastern Quebec [<a class="bk_pop" href="#arsacs.REF.bouchard.1978.61">Bouchard et al 1978</a>]. Little intra- and extrafamilial phenotypic variability has been observed among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals born in Quebec.</p><p>The clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in Quebec-born individuals is typically characterized by onset between age 12 and 18 months with difficulty in walking and gait unsteadiness [<a class="bk_pop" href="#arsacs.REF.bouchard.1991">Bouchard 1991</a>]. Spastic ataxia and dysarthria tend to worsen slowly but relentlessly in the preteen and teen years. A childhood-onset mixed sensorimotor peripheral neuropathy with both axonal and demyelinating features is observed in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. This leads to distal muscle atrophy and weakness, foot deformities, impaired tactile and vibration sense and (eventually) to a decrease or loss of tendon reflexes in the legs [<a class="bk_pop" href="#arsacs.REF.vermeer.2008.207">Vermeer et al 2008</a>]. Electrophysiology often confirms a mixed demyelinating and axonal neuropathy [<a class="bk_pop" href="#arsacs.REF.bouchard.1978.61">Bouchard et al 1978</a>, <a class="bk_pop" href="#arsacs.REF.garc_a.2008.107">Garc&#x000ed;a et al 2008</a>, <a class="bk_pop" href="#arsacs.REF.baets.2010.1181">Baets et al 2010</a>]. Distal amyotrophy, which leads to loss of ankle reflexes and sometimes bilateral foot drop, is found in most individuals after age 21 years. Other deep tendon reflexes remain brisk. Oculomotor disturbances, dysarthria, and upper limb ataxia usually progress much slower than gait ataxia, spasticity, and neuropathy.</p><p>A characteristic retinal finding is the presence of yellow streaks of hypermyelinated fibers radiating from the edges of the retina. Retinal nerve fiber hypertrophy as demonstrated on ocular coherence tomography (OCT) has been reported in several individuals with ARSACS [<a class="bk_pop" href="#arsacs.REF.pablo.2011.1871">Pablo et al 2011</a>].</p><p>Superior vermis atrophy, linear hypointensities in the pons, and atrophy of the cerebellar hemispheres and spinal cord can be seen on brain MRI [<a class="bk_pop" href="#arsacs.REF.martin.2007.1606">Martin et al 2007</a>].</p><p>Mitral valve prolapse, a frequent feature among individuals with ARSACS from Quebec [<a class="bk_pop" href="#arsacs.REF.bouchard.1978.61">Bouchard et al 1978</a>], has to date been reported in only one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual not of Quebec origin [<a class="bk_pop" href="#arsacs.REF.baets.2010.1181">Baets et al 2010</a>].</p><p>Since analysis for pathogenic variants became available, many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals outside Quebec have been molecularly characterized. Almost all affected individuals show the highly characteristic triad of cerebellar ataxia, peripheral neuropathy, and pyramidal tract signs.</p><p>Disease onset is typically in early childhood, although adult onset has also been described [<a class="bk_pop" href="#arsacs.REF.ogawa.2004.107">Ogawa et al 2004</a>, <a class="bk_pop" href="#arsacs.REF.baets.2010.1181">Baets et al 2010</a>]. The first signs of the disease are a slowly progressive cerebellar ataxia (which can lead to delayed walking because of gait unsteadiness in very young infants [<a class="bk_pop" href="#arsacs.REF.bouchard.1978.61">Bouchard et al 1978</a>]) usually with subsequent lower limb spasticity, followed by features of peripheral neuropathy. However, pronounced peripheral neuropathy as a first sign of ARSACS, followed by pyramidal and cerebellar signs, has also been observed. Often, this leads to significant and severe lower-limb and gait impairment.</p><p>To date, three individuals with molecularly proven ARSACS and an unusual <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (lacking either spasticity or peripheral neuropathy) have been described [<a class="bk_pop" href="#arsacs.REF.shimazaki.2005.2129">Shimazaki et al 2005</a>, <a class="bk_pop" href="#arsacs.REF.baets.2010.1181">Baets et al 2010</a>]. However, the two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals described by Shimazaki et al with absence of lower-limb spasticity both displayed bilateral Babinski signs indicating pyramidal involvement; here, the spasticity was likely masked by the severe neuropathy. In the third individual, from a Belgian cohort, clinical or electrophysiologic signs of peripheral neuropathy were lacking. Disease onset in this individual was unusually late (age 40 yrs); it may be that peripheral neuropathy has not yet developed.</p><p>Although IQ levels tend to be in the lower range of normal, in part as a result of the neurologic handicaps (e.g., severe dysarthria), most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are able to cope well with daily living tasks. Cognitive skills tend to be preserved into late adult life, although this is queried by recent observations. Detailed neuropsychiatric and neurophysiologic assessment was performed in two individuals with ARSACS. Apart from motor symptoms, motivational deficits along with cognitive and behavioral dysfunction were present, indicating that the cerebellum may also play a functional role in human cognition and affect [<a class="bk_pop" href="#arsacs.REF.verhoeven.2012.193">Verhoeven et al 2012</a>].</p><p>In two reported sibs with ARSACS from Quebec, death occurred in the sixth decade.</p></div><div id="arsacs.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Individuals with a microdeletion of 13q12.12 that encompasses <i>SACS</i> (and a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the other <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>) have a slightly different <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> consisting of hearing loss and learning difficulties in addition to the typical features of ARSACS [<a class="bk_pop" href="#arsacs.REF.breckpot.2008.1050">Breckpot et al 2008</a>, <a class="bk_pop" href="#arsacs.REF.terracciano.2009.151">Terracciano et al 2009</a>].</p></div><div id="arsacs.Prevalence"><h3>Prevalence</h3><p>The exact prevalence of ARSACS is unknown. Nearly 325 individuals with ARSACS have been followed for many years in specialized ataxia clinics in Quebec. The male-to-female ratio is nearly equal.</p><p>The estimated <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency of <i>SACS</i> pathogenic variants in the Saguenay-Lac-St-Jean (SLSJ) region of Quebec, northeast of Quebec City, Canada is 1:21, based on data gathered between 1941 and 1985 [<a class="bk_pop" href="#arsacs.REF.de_braekeleer.1991.141">De Braekeleer 1991</a>, <a class="bk_pop" href="#arsacs.REF.de_braekeleer.1993.17">De Braekeleer et al 1993</a>, <a class="bk_pop" href="#arsacs.REF.dupr_.2006.149">Dupr&#x000e9; et al 2006</a>]. The birth incidence of ARSACS was 1:1,932. Consanguinity was slightly increased (13%) within <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> kindreds. A <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> is largely suspected as the root cause of the high regional prevalence of ARSACS, which could date back to 1650, a date consistent with the arrival of the first carrier family from France. The geographic isolation of the SLSJ region from large urban areas during the 18th and 19th centuries played a role in the sustained high levels of hereditary transmission and local incidence of ARSACS.</p><p>Although initially confined to Quebec, genetically confirmed ARSACS has now been reported in individuals all over Europe, Tunisia, Japan, and Turkey [<a class="bk_pop" href="#arsacs.REF.criscuolo.2004.100">Criscuolo et al 2004</a>, <a class="bk_pop" href="#arsacs.REF.grieco.2004.103">Grieco et al 2004</a>, <a class="bk_pop" href="#arsacs.REF.ogawa.2004.107">Ogawa et al 2004</a>, <a class="bk_pop" href="#arsacs.REF.criscuolo.2005.1358">Criscuolo et al 2005</a>, <a class="bk_pop" href="#arsacs.REF.takiyama.2006.368">Takiyama 2006</a>, <a class="bk_pop" href="#arsacs.REF.vermeer.2008.207">Vermeer et al 2008</a>, <a class="bk_pop" href="#arsacs.REF.baets.2010.1181">Baets et al 2010</a>]. In a Belgian cohort of individuals with cerebellar ataxia suggestive of ARSACS, a relative prevalence of 13% was identified [<a class="bk_pop" href="#arsacs.REF.baets.2010.1181">Baets et al 2010</a>]. In another cohort of 232 (index) individuals with cerebellar ataxia, a comparable prevalence of 12% was found [Vermeer et al, unpublished data].</p><p>The true worldwide incidence of ARSACS remains unknown; it is likely underdiagnosed.</p></div></div><div id="arsacs.Genetically_Related_Allelic_Disor"><h2 id="_arsacs_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are associated with pathogenic variants in <i>SACS</i>.</p></div><div id="arsacs.Differential_Diagnosis"><h2 id="_arsacs_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Ataxia.</b> See <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>.</p><ul><li class="half_rhythm"><div>The classification of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> ataxias has been greatly expanded (for review, see <a class="bk_pop" href="#arsacs.REF.robitaille.2003">Robitaille et al [2003]</a> and <a class="bk_pop" href="#arsacs.REF.de_bot.2012.1507">de Bot et al [2012]</a>) with the inclusion of several new syndromes. Early-, juvenile-, and adult-onset types associated with diverse phenotypes from spastic paraplegia to intellectual disability may be excluded.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/friedreich/">Friedreich ataxia</a>, the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> ataxic disorder with the highest worldwide prevalence, may overlap with ARSACS. Friedreich ataxia is characterized by slowly progressive ataxia with onset usually before age 25 years. It is typically associated with depressed tendon reflexes, dysarthria, Babinski responses, and loss of position and vibration sense. A discriminating feature of Friedreich ataxia is the absence of the early-onset spasticity seen in ARSACS. MRI often does not show cerebellar atrophy until late in the disease; atrophy of the dentate nuclei is common. About 25% of individuals have an atypical presentation with onset after age 25 years, retained tendon reflexes, or unusually slow progression of disease. About two thirds of individuals have cardiomyopathy. Diabetes mellitus occurs in 10% of individuals. The far earlier onset of ARSACS, the absence of cardiomyopathy in ARSACS and the presence of hypermyelinated retinal fibers in Quebec-born persons with ARSACS help distinguish the two disorders. The vast majority of individuals with Friedreich ataxia have identifiable pathogenic variants in <i>FXN</i>. The most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, seen in more than 95% of individuals, is a GAA triplet-repeat expansion in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 1, which leads to transcription of mutated frataxin, an iron transporter localized in the mitochondria.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/aved/">Autosomal recessive ataxia with vitamin E deficiency</a> (AVED) (and more rarely, abetalipoproteinemia) may need to be excluded on the basis of clinical phenotypes and relevant laboratory tests. Malabsorption syndromes of various causes may also cause ataxia late in the disease course.</div></li><li class="half_rhythm"><div>An <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spastic ataxia involved 15 out of 34 candidate families in Morocco not linked to the SACS <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 13 [<a class="bk_pop" href="#arsacs.REF.bouslam.2007.413">Bouslam et al 2007</a>]. Dysarthria appeared first, followed by gait abnormalities. Age of onset was usually before 15 years; however, rarely persons first become symptomatic during early adulthood. A new locus, labeled SAX2, was found on chromosome 17p13.</div></li></ul><p><b>Spastic paraplegia.</b> See <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia</a>.</p><ul><li class="half_rhythm"><div>Most individuals with ARSACS first reported by <a class="bk_pop" href="#arsacs.REF.bouchard.1978.61">Bouchard et al [1978]</a> had been diagnosed as having cerebral palsy with spastic diplegia. Confusion with cerebral palsy and secondary spastic diplegia may in part explain the apparent low incidence of ARSACS in many parts of the world.</div></li><li class="half_rhythm"><div>SPG30 is characterized by early-onset unsteady spastic gait and hyperreflexia of lower limbs. Mildly impaired sensation and cerebellar involvement have been described [<a class="bk_pop" href="#arsacs.REF.klebe.2006.1456">Klebe et al 2006</a>]. Pathogenic variants in <i>KIF1A</i> have been associated with SPG30 [<a class="bk_pop" href="#arsacs.REF.erlich.2011.658">Erlich et al 2011</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/spg20/">Troyer syndrome</a> (also called SPG20), is caused by pathogenic variants in <i>SPART</i> [<a class="bk_pop" href="#arsacs.REF.patel.2002.347">Patel et al 2002</a>]. Troyer syndrome is characterized by spastic paraplegia with distal arm and leg amyotrophy, dysarthria, and mild cerebellar signs. It has a higher frequency in the Amish population than elsewhere in the world.</div></li><li class="half_rhythm"><div>Autosomal recessive spastic ataxia with leukoencephalopathy (ARSAL, spastic ataxia 3, SPAX3), is characterized by spastic ataxia and brain white matter changes [<a class="bk_pop" href="#arsacs.REF.thiffault.2006.2332">Thiffault et al 2006</a>]. Pathogenic variants in <i>MARS2</i> have recently been associated with ARSAL [<a class="bk_pop" href="#arsacs.REF.bayat.2012.e1001288">Bayat et al 2012</a>].</div></li></ul><p><b>Retinal streaks</b> may be observed in individuals without spastic ataxia or other neurodegenerative abnormalities. Recent ultrastructural observations have not corroborated the hypothesis that hypermyelinated fibers constitute the basic pathophysiology of retinal streaks in ARSACS.</p></div><div id="arsacs.Management"><h2 id="_arsacs_Management_">Management</h2><div id="arsacs.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with ARSACS (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spastic ataxia of Charlevoix-Saguenay), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Brain MRI</div></li><li class="half_rhythm"><div>Retinal examination</div></li><li class="half_rhythm"><div>EMG</div></li><li class="half_rhythm"><div>Clinical genetics consultation</div></li></ul></div><div id="arsacs.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Curative therapy is not available.</p><p>Physical therapy and use of oral medications such as baclofen to control spasticity in the early phase of the disease may prevent tendon shortening and joint contractures. These measures may help to postpone major functional disabilities until severe muscle weakness or cerebellar ataxia occur.</p><p>Urinary urgency and incontinence may be controlled with low doses of amitryptiline or oxybutynin.</p><p>During school years, speech therapy and psychological support may help enhance academic performance.</p></div><div id="arsacs.Surveillance"><h3>Surveillance</h3><p>Surveillance should include annual neurologic examination.</p></div><div id="arsacs.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#arsacs.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="arsacs.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Gene therapy may possibly be considered in the long term once transgenic models provide more specific clues on the molecular cascades of partially deleted or truncated sacsin and their effects on neuronal survival and functions that lead to the ARSACS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="arsacs.Genetic_Counseling"><h2 id="_arsacs_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="arsacs.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>ARSACS (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spastic ataxia of Charlevoix-Saguenay) is inherited in an autosomal recessive manner.</p></div><div id="arsacs.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are usually obligate heterozygotes and therefore carry one mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. A report of uniparental isodisomy of the paternal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 13 resulting in a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> p.Arg4378Ter <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in an affected individual suggests that not all parents are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> [<a class="bk_pop" href="#arsacs.REF.anesi.2011.346">Anesi et al 2011</a>].</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being neither affected nor a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with ARSACS are obligate heterozygotes for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SACS</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="arsacs.Carrier_Detection"><h3>Carrier Detection</h3><p>Carrier detection is possible if the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div><div id="arsacs.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>Population screening.</b> In the Saguenay-Lac-St-Jean (Quebec, Canada) population, the high <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency (1:21) could warrant population screening for reproductive purposes. In this population, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the two founder variants (6594delT and 5254C&#x0003e;T) detects 92.6% of carriers.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="arsacs.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for ARSACS are possible.</p></div></div><div id="arsacs.Resources"><h2 id="_arsacs_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Fondation de L'Ataxie Charlevoix-Saguenay</b></div><div>Ataxia Charlevoix-Saguenay Foundation</div><div>1000 Sherbrooke West</div><div>Suite 2100</div><div>Montr&#x000e9;al Quebec H3A 3G4</div><div>Canada</div><div><b>Phone:</b> 514-370-3625</div><div><b>Fax:</b> 514-370-3615</div><div><b>Email:</b> ataxia@arsacs.com</div><div><a href="https://www.arsacs.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.arsacs.com</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>International ARSACS Patient Registry</b></div><div><a href="https://www.arsacs.com/patient-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.arsacs.com/patient-registry</a></div></li></ul></div><div id="arsacs.Molecular_Genetics"><h2 id="_arsacs_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="arsacs.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>ARSACS: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1255/table/arsacs.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arsacs.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_arsacs.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_arsacs.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_arsacs.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_arsacs.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_arsacs.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_arsacs.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_arsacs.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/26278" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SACS</i></a></td><td headers="hd_b_arsacs.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=26278" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">13q12<wbr style="display:inline-block"></wbr>​.12</a></td><td headers="hd_b_arsacs.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NZJ4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sacsin</a></td><td headers="hd_b_arsacs.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SACS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SACS database</a></td><td headers="hd_b_arsacs.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SACS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SACS</a></td><td headers="hd_b_arsacs.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SACS[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SACS</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="arsacs.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="arsacs.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for ARSACS (<a href="/omim/270550,604490" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1255/table/arsacs.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arsacs.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/270550" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">270550</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604490" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604490</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SACSIN; SACS</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The reference sequence <a href="/nuccore/NM_014363.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014363.4</a> has ten (of which nine are coding) exons.</p><p><b>Pathogenic variants.</b> In a study of 164 alleles, 92.6% of individuals with ARSACS born in Quebec were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> 6594delT and 3.7% of individuals were <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for the common deletion and a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> 5254C&#x0003e;T variant [<a class="bk_pop" href="#arsacs.REF.richter.1999.768">Richter et al 1999</a>].</p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> (p.Arg3636Gln) associated with ARSACS has been identified in the Belgian population [<a class="bk_pop" href="#arsacs.REF.baets.2010.1181">Baets et al 2010</a>].</div></li><li class="half_rhythm"><div>The p.Gln4054Ter <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is common among Dutch persons with ARSACS [<a class="bk_pop" href="#arsacs.REF.vermeer.2008.207">Vermeer et al 2008</a>].</div></li></ul><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Sacsin is an 11.7-kb protein of yet-unknown function [<a class="bk_pop" href="#arsacs.REF.engert.2000.120">Engert et al 2000</a>]. The sacsin isoform <a href="/protein/NP_055178.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055178.3</a>, encoded by the transcript <a href="/nuccore/NM_014363.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014363.4</a>, has 4579 amino acid residues. The carboxy-terminus <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> harbors a 'DnaJ' motif that has the potential to interact with members of the HSP70 family of heat shock proteins and a ubiquitin-like domain suggesting that sacsin may play a specific cellular role linking the ubiquitin-proteosome pathway to the heat shock protein 70 machinery [<a class="bk_pop" href="#arsacs.REF.parfitt.2009.1556">Parfitt et al 2009</a>]. The N-terminus has extensive homology for HSP90, a subtype of heat shock protein that can act as a chaperone molecule important in the regulation of protein folding. Wild-type sacsin is expressed throughout the CNS, in skeletal muscles, and in skin fibroblasts. However, no knock-out transgenic models of ARSACS are yet available to assess the potential lethality of mutated sacsin.</p><p>Studies in sacsin knockout mice have shown that sacsin localizes to mitochondria in non-neuronal cells and primary neurons and that it interacts with dynamin-related protein 1, which participates in mitochondrial fission. Furthermore, it is likely that sacsin plays a role in the regulation of mitochondrial dynamics and that mitochondrial dysfunction/mislocalization is the cellular basis for ARSACS [<a class="bk_pop" href="#arsacs.REF.girard.2012.1661">Girard et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the 6594delT <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have complete loss of sacsin expression in skin fibroblasts as determined by immunocytochemical and western blot analyses. It is then likely that major deletions result in complete suppression of sacsin expression, including in the CNS. It is postulated that <i>SACS</i> pathogenic variants may interfere with protein folding and lead to significant loss of function in key signaling pathways even at an embryonic stage. Compound heterozygosity for less extensive deletions or single-nucleotide variants will result in the synthesis of a truncated sacsin molecule that may not be able to interact normally with other proteins.</p></div><div id="arsacs.References"><h2 id="_arsacs_References_">References</h2><div id="arsacs.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.anesi.2011.346">Anesi L, de Gemmis P, Pandolfo M, Hladnik U. Two novel homozygous SACS mutations in unrelated patients including the first reported case of paternal UPD as an etiologic cause of ARSACS. <span><span class="ref-journal">J Mol Neurosci. </span>2011;<span class="ref-vol">43</span>:346–9.</span> [<a href="/pubmed/20852969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20852969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.baets.2010.1181">Baets J, Deconinck T, Smets K, Goossens D, Van den Bergh P, Dahan K, Schmedding E, Santens P, Rasic VM, Van Damme P, Robberecht W, De Meirleir L, Michielsens B, Del-Favero J, Jordanova A, De Jonghe P. Mutations in SACS cause atypical and late-onset forms of ARSACS. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">75</span>:1181–8.</span> [<a href="/pubmed/20876471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20876471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.bayat.2012.e1001288">Bayat V, Thiffault I, Jaiswal M, T&#x000e9;treault M, Donti T, Sasarman F, Bernard G, Demers-Lamarche J, Dicaire MJ, Mathieu J, Vanasse M, Bouchard JP, Rioux MF, Lourenco CM, Li Z, Haueter C, Shoubridge EA, Graham BH, Brais B, Bellen HJ. Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans. <span><span class="ref-journal">PLoS Biol. </span>2012;<span class="ref-vol">10</span>:e1001288.</span> [<a href="/pmc/articles/PMC3308940/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3308940</span></a>] [<a href="/pubmed/22448145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22448145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.bouchard.1991">Bouchard JP. Recessive spastic ataxia of Charlevoix-Saguenay. In: de Jong JMBV, ed. <em>Handbook of Clinical Neurology 16: Hereditary Neuropathies and Spinocerebellar Degenerations.</em> Vol 60. Amsterdam, Netherlands: Elsevier; 1991:451-9.</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.bouchard.1978.61">Bouchard JP, Barbeau A, Bouchard R, Bouchard RW. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. <span><span class="ref-journal">Can J Neurol Sci. </span>1978;<span class="ref-vol">5</span>:61–9.</span> [<a href="/pubmed/647499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 647499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.bouslam.2007.413">Bouslam N, Bouhouche A, Benomar A, Hanein S, Klebe S, Azzedine H, Giandomenico SD, Boland-Auge A, Santorelli FM, Durr A, Brice A, Yahyaoui M, Stevanin G. A novel locus for autosomal recessive spastic ataxia on chromosome 17p. <span><span class="ref-journal">Hum Genet. </span>2007;<span class="ref-vol">121</span>:413–20.</span> [<a href="/pubmed/17273843" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17273843</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.breckpot.2008.1050">Breckpot J, Takiyama Y, Thienpont B, Van Vooren S, Vermeesch JR, Ortibus E, Devriendt K. A novel genomic disorder: a deletion of the SACS gene leading to spastic ataxia of Charlevoix-Saguenay. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:1050–4.</span> [<a href="/pubmed/18398442" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18398442</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.criscuolo.2004.100">Criscuolo C, Banfi S, Orio M, Gasparini P, Monticelli A, Scarano V, Santorelli FM, Perretti A, Santoro L, De Michele G, Filla A. A novel mutation in SACS gene in a family from southern Italy. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:100–2.</span> [<a href="/pubmed/14718706" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14718706</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.criscuolo.2005.1358">Criscuolo C, Sacca F, De Michele G, Mancini P, Combarros O, Infante J, Garcia A, Banfi S, Filla A, Berciano J. Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia. <span><span class="ref-journal">Mov Disord. </span>2005;<span class="ref-vol">20</span>:1358–61.</span> [<a href="/pubmed/16007637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16007637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.de_bot.2012.1507">de Bot ST, Willemsen MA, Vermeer S, Kremer HP, van de Warrenburg BP. Reviewing the genetic causes of spastic-ataxias. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">79</span>:1507–14.</span> [<a href="/pubmed/23033504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23033504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.de_braekeleer.1991.141">De Braekeleer M. Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada). <span><span class="ref-journal">Hum Hered. </span>1991;<span class="ref-vol">41</span>:141–6.</span> [<a href="/pubmed/1937486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1937486</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.de_braekeleer.1993.17">De Braekeleer M, Giasson F, Mathieu J, Roy M, Bouchard JP, Morgan K. Genetic epidemiology of autosomal recessive spastic ataxia of Charlevoix-Saguenay in northeastern Quebec. <span><span class="ref-journal">Genet Epidemiol. </span>1993;<span class="ref-vol">10</span>:17–25.</span> [<a href="/pubmed/8472930" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8472930</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.dupr_.2006.149">Dupr&#x000e9; N, Bouchard JP, Brais B, Rouleau GA. Hereditary ataxia, spastic paraparesis and neuropathy in the French-Canadian population. <span><span class="ref-journal">Can J Neurol Sci. </span>2006;<span class="ref-vol">33</span>:149–57.</span> [<a href="/pubmed/16736723" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16736723</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.erlich.2011.658">Erlich Y, Edvardson S, Hodges E, Zenvirt S, Thekkat P, Shaag A, Dor T, Hannon GJ, Elpeleg O. Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. <span><span class="ref-journal">Genome Res. </span>2011;<span class="ref-vol">21</span>:658–64.</span> [<a href="/pmc/articles/PMC3083082/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3083082</span></a>] [<a href="/pubmed/21487076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21487076</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.engert.2000.120">Engert JC, Berube P, Mercier J, Dore C, Lepage P, Ge B, Bouchard JP, Mathieu J, Melancon SB, Schalling M, Lander ES, Morgan K, Hudson TJ, Richter A. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">24</span>:120–5.</span> [<a href="/pubmed/10655055" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10655055</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.garc_a.2008.107">Garc&#x000ed;a A, Criscuolo C, de Michele G, Berciano J. Neurophysiological study in a Spanish family with recessive spastic ataxia of Charlevoix-Saguenay. <span><span class="ref-journal">Muscle Nerve. </span>2008;<span class="ref-vol">37</span>:107–10.</span> [<a href="/pubmed/17683082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17683082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.girard.2012.1661">Girard M, Larivi&#x000e8;re R, Parfitt DA, Deane EC, Gaudet R, Nossova N, Blondeau F, Prenosil G, Vermeulen EG, Duchen MR, Richter A, Shoubridge EA, Gehring K, McKinney RA, Brais B, Chapple JP, McPherson PS. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2012;<span class="ref-vol">109</span>:1661–6.</span> [<a href="/pmc/articles/PMC3277168/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3277168</span></a>] [<a href="/pubmed/22307627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22307627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.grieco.2004.103">Grieco GS, Malandrini A, Comanducci G, Leuzzi V, Valoppi M, Tessa A, Palmeri S, Benedetti L, Pierallini A, Gambelli S, Federico A, Pierelli F, Bertini E, Casali C, Santorelli FM. Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:103–6.</span> [<a href="/pubmed/14718707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14718707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.klebe.2006.1456">Klebe S, Azzedine H, Durr A, Bastien P, Bouslam N, Elleuch N, Forlani S, Charon C, Koenig M, Melki J, Brice A, Stevanin G. Autosomal recessive spastic paraplegia (SPG30) with mild ataxia and sensory neuropathy maps to chromosome 2q37.3. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:1456–62.</span> [<a href="/pubmed/16434418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16434418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.martin.2007.1606">Martin MH, Bouchard JP, Sylvain M, St-Onge O, Truchon S. Autosomal recessive spastic ataxia of Charlevoix-Saguenay: a report of MR imaging in 5 patients. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2007;<span class="ref-vol">28</span>:1606–8.</span> [<a href="/pubmed/17846221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17846221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.mercier.2001.255">Mercier J, Prevost C, Engert JC, Bouchard JP, Mathieu J, Richter A. Rapid detection of the sacsin mutations causing autosomal recessive spastic ataxia of Charlevoix-Saguenay. <span><span class="ref-journal">Genet Test. </span>2001;<span class="ref-vol">5</span>:255–9.</span> [<a href="/pubmed/11788093" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11788093</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.ogawa.2004.107">Ogawa T, Takiyama Y, Sakoe K, Mori K, Namekawa M, Shimazaki H, Nakano I, Nishizawa M. Identification of a SACS gene missense mutation in ARSACS. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:107–9.</span> [<a href="/pubmed/14718708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14718708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.pablo.2011.1871">Pablo LE, Garcia-Martin E, Gazulla J, Larrosa JM, Ferreras A, Santorelli FM, Benavente I, Vela A, Marin MA. Retinal nerve fiber hypertrophy in ataxia of Charlevoix-Saguenay patients. <span><span class="ref-journal">Mol Vis. </span>2011;<span class="ref-vol">17</span>:1871–6.</span> [<a href="/pmc/articles/PMC3144729/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3144729</span></a>] [<a href="/pubmed/21850161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21850161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.parfitt.2009.1556">Parfitt DA, Michael GJ, Vermeulen EG, Prodromou NV, Webb TR, Gallo JM, Cheetham ME, Nicoll WS, Blatch GL, Chapple JP. The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:1556–65.</span> [<a href="/pmc/articles/PMC2667285/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2667285</span></a>] [<a href="/pubmed/19208651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19208651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.patel.2002.347">Patel H, Cross H, Proukakis C, Hershberger R, Bork P, Ciccarelli FD, Patton MA, McKusick VA, Crosby AH. SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">31</span>:347–8.</span> [<a href="/pubmed/12134148" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12134148</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.richter.1999.768">Richter A, Rioux JD, Bouchard JP, Mercier J, Mathieu J, Ge B, Poirier J, Julien D, Gyapay G, Weissenbach J, Hudson TJ, Melancon SB, Morgan K. Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:768–75.</span> [<a href="/pmc/articles/PMC1377794/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377794</span></a>] [<a href="/pubmed/10053011" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10053011</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.robitaille.2003">Robitaille Y, Klockgether T, Lamarche JB. Friedrich's ataxia. In: Dickson D, ed. <em>Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders.</em> Basel, Switzerland: ISN Neuropath Press; 2003:257-68.</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.shimazaki.2005.2129">Shimazaki H, Takiyama Y, Sakoe K, Ando Y, Nakano I. A phenotype without spasticity in sacsin-related ataxia. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:2129–31.</span> [<a href="/pubmed/15985586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15985586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.takiyama.2006.368">Takiyama Y. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. <span><span class="ref-journal">Neuropathology. </span>2006;<span class="ref-vol">26</span>:368–75.</span> [<a href="/pubmed/16961075" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16961075</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.terracciano.2009.151">Terracciano A, Casali C, Grieco GS, Orteschi D, Di Giandomenico S, Seminara L, Di Fabio R, Carrozzo R, Simonati A, Stevanin G, Zollino M, Santorelli FM. An inherited large-scale rearrangement in SACS associated with spastic ataxia and hearing loss. <span><span class="ref-journal">Neurogenetics. </span>2009;<span class="ref-vol">10</span>:151–5.</span> [<a href="/pubmed/19031088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19031088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.thiffault.2006.2332">Thiffault I, Rioux MF, Tetreault M, Jarry J, Loiselle L, Poirier J, Gros-Louis F, Mathieu J, Vanasse M, Rouleau GA, Bouchard JP, Lesage J, Brais B. A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:2332–40.</span> [<a href="/pubmed/16672289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16672289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.verhoeven.2012.193">Verhoeven WM, Egger JI, Ahmed AI, Kremer BP, Vermeer S, van de Warrenburg BP. Cerebellar cognitive affective syndrome and autosomal recessive spastic ataxia of charlevoix-saguenay: a report of two male sibs. <span><span class="ref-journal">Psychopathology. </span>2012;<span class="ref-vol">45</span>:193–9.</span> [<a href="/pubmed/22441213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22441213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arsacs.REF.vermeer.2008.207">Vermeer S, Meijer RP, Pijl BJ, Timmermans J, Cruysberg JR, Bos MM, Schelhaas HJ, van de Warrenburg BP, Knoers NV, Scheffer H, Kremer B. ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia. <span><span class="ref-journal">Neurogenetics. </span>2008;<span class="ref-vol">9</span>:207–14.</span> [<a href="/pmc/articles/PMC2441586/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2441586</span></a>] [<a href="/pubmed/18465152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18465152</span></a>]</div></li></ul></div></div><div id="arsacs.Chapter_Notes"><h2 id="_arsacs_Chapter_Notes_">Chapter Notes</h2><div id="arsacs.Author_History"><h3>Author History</h3><p>Jean-Pierre Bouchard, MD; Laval University (2003-2012)<br />Erik-Jan Kamsteeg, PhD (2012-present)<br />Jean Mathieu, MD, FRCPC; Complexe Hospitalier de la Sagamie (2003-2012)<br />Andrea Richter, PhD; University of Montreal (2003-2012)<br />Yves Robitaille, MD, FCAP; University of Montreal (2003-2012)<br />Bart P van de Warrenburg, MD, PhD (2012-present)<br />Sascha Vermeer, MD, PhD (2012-present)</p></div><div id="arsacs.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 October 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 April 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 January 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 December 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>2 July 2003 (yr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1255</span><span class="label">PMID: <a href="/pubmed/20301432" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301432</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/arid1b-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/asah1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1255&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1255/?report=reader">PubReader</a></li><li><a href="/books/NBK1255/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1255" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1255" style="display:none" title="Cite this Page"><div class="bk_tt">Vermeer S, van de Warrenburg BP, Kamsteeg EJ. ARSACS. 2003 Dec 9 [Updated 2012 Oct 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1255/pdf/Bookshelf_NBK1255.pdf">PDF version of this page</a> (178K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#arsacs.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#arsacs.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#arsacs.Clinical_Description" ref="log$=inpage&amp;link_id=inpage">Clinical Description</a></li><li><a href="#arsacs.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#arsacs.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#arsacs.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#arsacs.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#arsacs.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#arsacs.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#arsacs.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#arsacs.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=26278[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SACS</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1255+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1487552" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1487552" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1487552" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1487552" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23497566" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum.</a><span class="source">[Orphanet J Rare Dis. 2013]</span><div class="brieflinkpop offscreen_noflow">Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Synofzik M, Soehn AS, Gburek-Augustat J, Schicks J, Karle KN, Schüle R, Haack TB, Schöning M, Biskup S, Rudnik-Schöneborn S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2013 Mar 15; 8:41. Epub 2013 Mar 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17853117" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Sacsinopathies: sacsin-related ataxia.</a><span class="source">[Cerebellum. 2007]</span><div class="brieflinkpop offscreen_noflow">Sacsinopathies: sacsin-related ataxia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Takiyama Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cerebellum. 2007; 6(4):353-9. Epub 2007 Feb 28.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30271475" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: A Turkish Child.</a><span class="source">[J Pediatr Neurosci. 2018]</span><div class="brieflinkpop offscreen_noflow">Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: A Turkish Child.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Incecik F, Hergüner OM, Bisgin A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Pediatr Neurosci. 2018 Jul-Sep; 13(3):355-357. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301286" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 7</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 7<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Casari G, Marconi R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301718" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301432" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301432" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04171875f66d18aa6a3a72">ARSACS - GeneReviews®</a><div class="ralinkpop offscreen_noflow">ARSACS - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:12:41-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BAF56E0404AC10000000007B002CC&amp;ncbi_session=CE8BAF56E0417181_1968SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1255%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1255&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1255/&amp;ncbi_pagename=ARSACS - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BAF56E0417181_1968SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>